Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression (scientific article published on 11 December 2009)

Overexpression of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells

Q43606516

Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues

Q44131360

Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer.

Q44285244

A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates

Q22010732

Molecular cloning and expression of a human chondroitin synthase

Q24291588

Multiple domains of the large fibroblast proteoglycan, versican

Q24329098

Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression

Q24533672

Significance analysis of microarrays applied to the ionizing radiation response

Q24606608

Genes that mediate breast cancer metastasis to the brain

Q24644008

Cluster analysis and display of genome-wide expression patterns

Q24644463

Targeting selectins and selectin ligands in inflammation and cancer

Q24658204

Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy

Q28118938

Versican interacts with chemokines and modulates cellular responses

Q28138079

Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro

Q28143154

Mucins in cancer: protection and control of the cell surface

Q28235006

Cell surface-associated mucins in signal transduction

Q28257314

Siglecs--the major subfamily of I-type lectins

Q28261393

Proteoglycans in atherosclerosis and restenosis: key roles for versican

Q28261672

Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation

Q28281057

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

Q28281686

Galectins: structure, function and therapeutic potential

Q28283659

Matrix proteoglycans: from molecular design to cellular function

Q28284300

A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1

Q28299810

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

Q28305755

Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice

Q28585434

Microenvironmental regulation of metastasis

Q29547660

Epithelial-mesenchymal transitions in development and pathologies

Q29614986

Glycosylation profile of integrin alpha 3 beta 1 changes with melanoma progression

Q31030623

The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.

Q31705505

Pathways of O-glycan biosynthesis in cancer cells

Q33783697

Neoplastic alteration of a membrane-associated sialidase of rat liver

Q44738129

Sialidase activity in transformed cells

Q44790959

Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase III and the bisected N-glycans in GE11 epithelial cells. Involvement of E-cadherin-mediated cell adhesion

Q46990459

Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression.

Q47854825

Differential sulfations and epimerization define heparan sulfate specificity in nervous system development

Q48202252

Developmental regulation of the sulfation profile of chondroitin sulfate chains in the chicken embryo brain

Q48541947

Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members.

Q50335972

MUC1 mucin core protein binds to the domain 1 of ICAM-1.

Q52828650

UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.

Q53352914

Cartilaginous features in matrix-producing carcinoma of the breast: four cases report with histochemical and immunohistochemical analysis of matrix molecules.

Q53466686

Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis

Q53550210

Expression of different proteoglycans in human breast tumors

Q62602356

Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells

Q68202502

Distribution of oncofetal fibronectin in human mammary tumors: immunofluorescence study on histological sections

Q68929063

Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates

Q69070622

Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin

Q69620642

Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6)

Q70590724

Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis

Q71143181

E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers

Q71669739

Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer

Q71730619

Progression and recapitulation of the chondrocyte differentiation program: cartilage matrix protein is a marker for cartilage maturation

Q71816807

Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain

Q72728094

Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy

Q72875177

Lumican and decorin are differentially expressed in human breast carcinoma

Q73131531

An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas

Q73182063

Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin

Q73300727

Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line

Q73865012

Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewisx, the carbohydrate ligands for E-selectin, in human breast cancer

Q74430162

The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1

Q75208231

Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines

Q33813114

Lecticans: organizers of the brain extracellular matrix

Q33892208

The glycosynapse

Q33897219

A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications

Q33965561

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

Q33968610

Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways

Q34155054

All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases

Q34183333

Molecular Cloning of a Chondroitin Polymerizing Factor That Cooperates with Chondroitin Synthase for Chondroitin Polymerization

Q34193037

Chondroitin sulfate synthase-2. Molecular cloning and characterization of a novel human glycosyltransferase homologous to chondroitin sulfate glucuronyltransferase, which has dual enzymatic activities

Q34199064

Sulfotransferases in glycosaminoglycan biosynthesis

Q34271228

Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate

Q34271235

Galectins as modulators of tumour progression

Q34381235

Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells

Q34563122

Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions

Q34683362

Biological function of fucosylation in cancer biology

Q34740910

Cell signaling through membrane mucins

Q35036941

Sialidase and malignancy: a minireview

Q35748328

Regulation of integrin functions by N-glycans

Q35910283

Fibroblast growth factor signaling in tumorigenesis

Q36111404

Glycans in cancer and inflammation--potential for therapeutics and diagnostics

Q36148438

Molecular mechanisms of Lewis antigen expression.

Q36157494

The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis

Q36393281

Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines

Q36447574

Lewis x antigen mediates adhesion of human breast carcinoma cells to activated endothelium. Possible involvement of the endothelial scavenger receptor C-type lectin.

Q36528710

Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains

Q36559844

Extracellular matrix of ovarian tumors.

Q36582459

Mucin-type O-glycosylation and its potential use in drug and vaccine development

Q36995685

Branched N-glycans regulate the biological functions of integrins and cadherins.

Q37126755

Hyaluronidases in cancer biology

Q37166019

N-Glycans in cancer progression

Q37243167

Lumican, a small leucine-rich proteoglycan.

Q37307767

The structure of glycosaminoglycans and their interactions with proteins.

Q37353143

Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.

Q37367583

Enzyme activity in invasive tumors of human breast and colon

Q37443772

Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside).

Q37621813

Desulfated galactosaminoglycans are potential ligands for galectins: evidence from frontal affinity chromatography.

Q38290062

Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines

Q38292486

Recombinant human interleukins IL-1alpha, IL-1beta, IL-4, IL-6, and IL-7 show different and specific calcium-independent carbohydrate-binding properties

Q38307270

Molecular risk assessment for breast cancer development in patients with ductal hyperplasias

Q38427711

Identification of the active site of DS-epimerase 1 and requirement of N-glycosylation for enzyme function

Q39917747

N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration

Q40238492

A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.

Q40384632

Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.

Q40508811

Beta1,4-N-Acetylglucosaminyltransferase III down-regulates neurite outgrowth induced by costimulation of epidermal growth factor and integrins through the Ras/ERK signaling pathway in PC12 cells.

Q40623483

Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression

Q40759583

Gangliosides and antitumor immunity

Q40771118

Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.

Q40860247

Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain.

Q40947264

Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA.

Q41080602

Growth control of human foreskin fibroblasts and inhibition of extracellular sialidase activity by 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

Q41438968

Metastatic potential of transformed rat 3Y1 cell lines is inversely correlated with lysosomal-type sialidase activity

Q41450272

Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity.

Q41473286

Glycosphingolipid antigens and cancer therapy

Q41504998

Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer.

Q41594926

Multiple Forms of Mammalian Sialidase. Altered Expression in Carcinogenesis

Q41602350

Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium

Q41683514

New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins

Q41725563

Localization of globoside and Forssman glycolipids on erythrocyte membranes

Q42252711

Characterization of sialosylated Lewisx as a new tumor-associated antigen.

Q42822723

Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression.

Q43540226

Cell cycle regulation by galectin-12, a new member of the galectin superfamily

Q43562685

P433

issue

P921

main subject

diagnosis

Q16644043

P304

page(s)

98-118

P577

publication date

2009-12-11

P1433

published in

Molecular Oncology

Q2190736

P1476

title

Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression

P478

volume

Reverse relations

cites work (P2860)

Q36297916	A standardized method for lectin microarray-based tissue glycome mapping
Q38298363	Affinity biosensors for tumor-marker analysis
Q61447511	Alterations in the glycome after HDAC inhibition impact oncogenic potential in epigenetically plastic SW13 cells
Q34713253	An ensemble prognostic model for colorectal cancer
Q47664454	Analyzing epigenetic control of galectin expression indicates silencing of galectin-12 by promoter methylation in colorectal cancer.
Q57168005	Cancer Cell Glycocalyx and Its Significance in Cancer Progression
Q38171440	Cell surface protein glycosylation in cancer
Q38288595	Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology.
Q33674704	Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.
Q48221411	Chondroitin sulfate-mediated N-cadherin/β-catenin signaling is associated with basal-like breast cancer cell invasion.
Q35558089	Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells
Q41285443	Comparing the Immunoexpression of FUT3 and FUT6 between Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia
Q36492855	Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer
Q45064880	Cytotoxic protein from the mushroom Coprinus comatus possesses a unique mode for glycan binding and specificity.
Q36278033	Differential N-Glycosylation Patterns in Lung Adenocarcinoma Tissue
Q92857993	Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate Cancer
Q37502422	Divergent Synthesis of Chondroitin Sulfate Disaccharides and Identification of Sulfate Motifs that Inhibit Triple Negative Breast Cancer
Q40232992	Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer
Q26748089	Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer
Q38968841	Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.
Q91732659	Evaluation of GALNT16 polymorphisms to breast cancer risk in Chinese population
Q37372711	Evaluation of glycophenotype in breast cancer by quantum dot-lectin histochemistry
Q30418119	Evolutional and clinical implications of the epigenetic regulation of protein glycosylation.
Q35188301	Exploiting topological constraints to reveal buried sequence motifs in the membrane-bound N-linked oligosaccharyl transferases
Q64063284	Exploration of carbohydrate binding behavior and anti-proliferative activities of Arisaema tortuosum lectin
Q36506915	Generation of 2,000 breast cancer metabolic landscapes reveals a poor prognosis group with active serotonin production
Q39042751	Glycan-related gene expression signatures in breast cancer subtypes; relation to survival
Q37365408	Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge
Q37983930	Glycosaminoglycans: key players in cancer cell biology and treatment
Q26765743	Glycosylated Notch and Cancer
Q38569702	Glycosylation in cancer: mechanisms and clinical implications
Q34897367	Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.
Q37832163	Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer
Q59132146	Improving Immunotherapy Through Glycodesign
Q34029050	Interstitial guidance of cancer invasion
Q51168862	Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases.
Q50569294	Markers of Inflammation and Incident Breast Cancer Risk in the Women's Health Study.
Q34328293	Methylation markers of early-stage non-small cell lung cancer
Q34111293	Modifications of glycans: biological significance and therapeutic opportunities
Q28300581	Molecular carcinogenesis of canine mammary tumors: news from an old disease
Q60907601	Monitoring glycosylation metabolism in brain and breast cancer by Raman imaging
Q92453384	N-Glycan profiling of lung adenocarcinoma in patients at different stages of disease
Q37619873	N-acetylgalactosaminyltransferases in cancer
Q35016962	New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells
Q35069229	Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis
Q38911366	Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties
Q64999397	Role of glycosylation in hypoxia-driven cell migration and invasion.
Q39453175	Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.
Q40592492	Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome
Q91525853	Study of the interactions of a novel monoclonal antibody, mAb059c, with the hPD-1 receptor
Q60909196	The Function of Fucosylation in Progression of Lung Cancer
Q37784307	The Roles of Chondroitin-4-Sulfotransferase-1 in Development and Disease
Q35172546	The emerging importance of α-L-fucose in human breast cancer: a review.
Q38883962	Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer.
Q53671728	[Role of Fucosylation in Cancer].
Q46719191	sp2 -Iminosugar α-glucosidase inhibitor 1-C-octyl-2-oxa-3-oxocastanospermine specifically affected breast cancer cell migration through Stim1, β1-integrin, and FAK signaling pathways.